On the public citation graph
Discovery and Development of Galeterone (TOK-001 or VN/124-1) for the Treatment of All Stages of Prostate Cancer
0 signed · 245 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1002/1097-0142(19930201)71:3+<1068::aid-cncr2820711427>3.0.co;2-5openalex-snapshot
Ketoconazole and liarozole in the treatment of advanced prostatic cancer
inferredcites →https://doi.org/10.1002/cncr.28929openalex-snapshot
Quo vadis: Advanced prostate cancer—clinical care and clinical research in the era of multiple androgen receptor‐directed therapies
inferredcites →https://doi.org/10.1006/abio.1998.2993openalex-snapshot
Cytochrome P450c17-ExpressingEscherichia colias a First-Step Screening System for 17α-Hydroxylase- C17,20-lyase Inhibitors
inferredcites →https://doi.org/10.1007/978-1-4613-1731-9_4openalex-snapshot
Aromatase Inhibitors as New Endocrine Therapy for Breast Cancer
inferredcites →https://doi.org/10.1007/s00280-003-0603-2openalex-snapshot
Pharmacokinetics of novel inhibitors of androgen synthesis after intravenous administration in mice
inferredcites →https://doi.org/10.1016/0163-7258(93)90033-aopenalex-snapshot
Aromatease, its inhibitors and their use in breast cancer treatment
inferredcites →https://doi.org/10.1016/0960-0760(92)90134-5openalex-snapshot
4-pregnene-3-one-20β-carboxaldehyde: A potent inhibitor of 17α-hydroxylase/C17,20-lyase and of 5α-reductase
inferredcites →https://doi.org/10.1016/0968-0896(96)00138-1openalex-snapshot
20-Amino and 20,21-aziridinyl pregnene steroids: Development of potent inhibitors of 17α-hydroxylase/C17,20-lyase (P450 17)
inferredcites →https://doi.org/10.1016/j.bmc.2011.08.066openalex-snapshot
Discovery of orteronel (TAK-700), a naphthylmethylimidazole derivative, as a highly selective 17,20-lyase inhibitor with potential utility in the treatment of prostate cancer
inferredcites →https://doi.org/10.1016/j.jsbmb.2004.07.006openalex-snapshot
Potent CYP17 inhibitors: improved syntheses, pharmacokinetics and anti-tumor activity in the LNCaP human prostate cancer model
inferredcites →https://doi.org/10.1016/j.jsbmb.2010.11.005openalex-snapshot
CYP17 inhibitors for prostate cancer therapy
inferredcites →https://doi.org/10.1016/j.jsbmb.2011.02.001openalex-snapshot
Aromatase, aromatase inhibitors, and breast cancer
inferredcites →https://doi.org/10.1016/j.steroids.2011.06.002openalex-snapshot
Synthesis and biological evaluations of putative metabolically stable analogs of VN/124-1 (TOK-001): Head to head anti-tumor efficacy evaluation of VN/124-1 (TOK-001) and abiraterone in LAPC-4 human prostate cancer xenograft model
inferredcites →https://doi.org/10.1016/s0960-0760(00)00131-xopenalex-snapshot
Pregnenolone stimulates LNCaP prostate cancer cell growth via the mutated androgen receptor
inferredcites →https://doi.org/10.1016/s0960-0760(01)00096-6openalex-snapshot
Pharmacokinetic profile of 3β-hydroxy-17-(1H-1,2,3-triazol-1-yl)androsta-5,16-diene (VN/87-1), a potent androgen synthesis inhibitor, in mice
inferredcites →https://doi.org/10.1016/s0960-0760(99)00129-6openalex-snapshot
Effects of novel 17-azolyl compounds on androgen synthesis in vitro and in vivo
inferredcites →https://doi.org/10.1016/s0960-894x(96)00512-4openalex-snapshot
Nucleophilic vinylic “addition-elimination” substitution reaction of 3β-acetoxy-17-chloro-16-formylandrosta-5,16-diene: A novel and general route to 17-substituted steroids. Part 1 - synthesis of novel 17-azolyl-Δ16 steroids; inhibitors of 17α-hydroxylase/17, 20-lyase (17α-lyase)
inferredcites →https://doi.org/10.1021/ja002033kopenalex-snapshot
Natural Product-like Combinatorial Libraries Based on Privileged Structures. 1. General Principles and Solid-Phase Synthesis of Benzopyrans
inferredcites →https://doi.org/10.1021/jm020576uopenalex-snapshot
Three Dimensional Pharmacophore Modeling of Human CYP17 Inhibitors. Potential Agents for Prostate Cancer Therapy
inferredcites →https://doi.org/10.1021/jm040202wopenalex-snapshot
Novel C-17-Heteroaryl Steroidal CYP17 Inhibitors/Antiandrogens: Synthesis, in Vitro Biological Activity, Pharmacokinetics, and Antitumor Activity in the LAPC4 Human Prostate Cancer Xenograft Model
inferredcites →https://doi.org/10.1021/jm400048vopenalex-snapshot
Systematic Structure Modifications of Multitarget Prostate Cancer Drug Candidate Galeterone To Produce Novel Androgen Receptor Down-Regulating Agents as an Approach to Treatment of Advanced Prostate Cancer
inferredcites →https://doi.org/10.1021/jm970568ropenalex-snapshot
Novel 17-Azolyl Steroids, Potent Inhibitors of Human Cytochrome 17α-Hydroxylase-C17,20-lyase (P45017α): Potential Agents for the Treatment of Prostate Cancer
inferredcites →https://doi.org/10.1038/onc.2013.235openalex-snapshot
Androgen receptor functions in castration-resistant prostate cancer and mechanisms of resistance to new agents targeting the androgen axis
inferredcites →https://doi.org/10.1038/sj.bjc.6605882openalex-snapshot
Prolonging hormone sensitivity in prostate cancer xenografts through dual inhibition of AR and mTOR
inferredcites →https://doi.org/10.1038/sj.bjc.6690739openalex-snapshot
Effects of new 17α-hydroxylase/C17,20-lyase inhibitors on LNCaP prostate cancer cell growth in vitro and in vivo
inferredcites →https://doi.org/10.1046/j.1464-410x.2003.04026.xopenalex-snapshot
The role of antiandrogen monotherapy in the treatment of prostate cancer
inferredcites →https://doi.org/10.1110/ps.051905906openalex-snapshot
Comparison of crystal structures of human androgen receptor ligand‐binding domain complexed with various agonists reveals molecular determinants responsible for binding affinity
inferredcites →https://doi.org/10.1158/0008-5472.can-11-3948openalex-snapshot
ARN-509: A Novel Antiandrogen for Prostate Cancer Treatment
inferredcites →https://doi.org/10.1158/1535-7163.mct-07-0581openalex-snapshot
Synergistic effect of a novel antiandrogen, VN/124-1, and signal transduction inhibitors in prostate cancer progression to hormone independence in vitro
inferredcites →https://doi.org/10.1158/1535-7163.mct-08-0230openalex-snapshot
Androgen receptor inactivation contributes to antitumor efficacy of 17α-hydroxylase/17,20-lyase inhibitor 3β-hydroxy-17-(1H-benzimidazole-1-yl)androsta-5,16-diene in prostate cancer
inferredcites →https://doi.org/10.1158/1535-7163.mct-08-0336openalex-snapshot
17α-Hydroxylase/17,20 lyase inhibitor VN/124-1 inhibits growth of androgen-independent prostate cancer cells via induction of the endoplasmic reticulum stress response
inferredcites →https://doi.org/10.1158/1535-7163.targ-13-c89openalex-snapshot
Abstract C89: Galeterone suppresses castration-resistant and enzalutamide-resistant prostate cancer growth in vitro.
inferredcites →https://doi.org/10.1158/1538-7445.am2012-ct-07openalex-snapshot
Abstract CT-07: ARMOR1: Safety of galeterone (TOK-001) in a Phase 1 clinical trial in chemotherapy naive patients with castration resistant prostate cancer (CRPC)
inferredcites →https://doi.org/10.1200/jco.2009.24.1281openalex-snapshot
Phase I Clinical Trial of the CYP17 Inhibitor Abiraterone Acetate Demonstrating Clinical Activity in Patients With Castration-Resistant Prostate Cancer Who Received Prior Ketoconazole Therapy
inferredcites →https://doi.org/10.1200/jco.2012.30.15_suppl.4665openalex-snapshot
Phase I clinical trial of galeterone (TOK-001), a multifunctional antiandrogen and CYP17 inhibitor in castration resistant prostate cancer (CRPC).
inferredcites →https://doi.org/10.1200/jco.2013.31.15_suppl.e16075openalex-snapshot
Comparison of the pharmacokinetics (PK) of galeterone novel oral formulations.
inferredcites →https://doi.org/10.1200/jco.2013.31.6_suppl.184openalex-snapshot
Differential effects of galeterone, abiraterone, orteronel, and ketoconazole on CYP17 and steroidogenesis.
inferredcites →https://doi.org/10.1200/jco.2014.32.15_suppl.5029openalex-snapshot
Galeterone in men with CRPC: Results in four distinct patient populations from the ARMOR2 study.
inferredcites →https://doi.org/10.1200/jco.2014.32.4_suppl.7openalex-snapshot
Results from a phase 3, randomized, double-blind, multicenter, placebo-controlled trial of orteronel (TAK-700) plus prednisone in patients with metastatic castration-resistant prostate cancer (mCRPC) that has progressed during or following docetaxel-based therapy (ELM-PC 5 trial).
inferredcites →https://doi.org/10.1200/jco.2014.32.4_suppl.71openalex-snapshot
ARMOR2: Galeterone in progressive CRPC patients who have failed oral therapy.
inferredcites →https://doi.org/10.2147/dddt.s15850openalex-snapshot
Abiraterone acetate: oral androgen biosynthesis inhibitor for treatment of castration-resistant prostate cancer
inferredcites →https://doi.org/10.2174/1381612805666230109214333openalex-snapshot
Inhibitors of 17α-Hydroxylase/17,20-Lyase (CYPl7): Potential Agents for the Treatment of Prostate Cancer
inferredcites →https://doi.org/10.3390/ijms140713958openalex-snapshot
Recent Progress in Pharmaceutical Therapies for Castration-Resistant Prostate Cancer
inferredcites →https://doi.org/10.4155/fmc.10.14openalex-snapshot
Novel, Potent Anti-Androgens of Therapeutic Potential: Recent Advances and Promising Developments
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.2139/ssrn.4825103openalex-extracted
Steroidal 21-Imidazolium Salt Derivatives: Synthesis and Antitumoral Activity
inferred← citeshttps://doi.org/10.1002/0471266949.bmc055.pub2openalex-snapshot
Modulation of the Androgen Receptor Axis
inferred← citeshttps://doi.org/10.1002/1878-0261.70009openalex-snapshot
Thermal proteome profiling and proteome analysis using high‐definition mass spectrometry demonstrate modulation of cholesterol biosynthesis by next‐generation galeterone analog VNPP 433‐3β in castration‐resistant prostate cancer
inferred← citeshttps://doi.org/10.1002/9781119774198.ch2openalex-snapshot
Stability of Steroid Hormone Receptors
inferred← citeshttps://doi.org/10.1002/asia.202400595openalex-snapshot
Difluoroboron Complexes as Versatile Precursors for Steroid Modification. Lumiestrone‐Based Steroid Derivatives: Synthesis and Structural Studies
inferred← citeshttps://doi.org/10.1002/cam4.3101openalex-snapshot
Clinical outcomes of abiraterone acetate and predictors of its treatment duration in metastatic castration‐resistant prostate cancer: Real‐world experience in the Southeast Asian cohort
inferred← citeshttps://doi.org/10.1002/cbdv.202200648openalex-snapshot
Design, Synthesis and Anticancer Activity of Novel Steroidal Derivatives with D‐Ring Fused or Substituted N‐Heterocyclic Systems
inferred← citeshttps://doi.org/10.1002/cmdc.202000966openalex-snapshot
Design, Synthesis and Biological Evaluation of Steroidal Glycoconjugates as Potential Antiproliferative Agents
inferred← citeshttps://doi.org/10.1002/cpt.256openalex-snapshot
Androgen receptor targeting drugs in castration‐resistant prostate cancer and mechanisms of resistance
inferred← citeshttps://doi.org/10.1002/jhet.3070openalex-snapshot
Synthesis of Heterocyclic‐Substituted Novel Hydroxysteroids with Regioselective and Stereoselective Reactions
inferred← citeshttps://doi.org/10.1002/jhet.4174openalex-snapshot
Heterocyclic steroids: Synthetic routes and biological characteristics of steroidal fused bicyclic pyrimidines
inferred← citeshttps://doi.org/10.1002/jlcr.3516openalex-snapshot
Effect of N‐methyl deuteration on pharmacokinetics and pharmacodynamics of enzalutamide
inferred← citeshttps://doi.org/10.1002/med.21548openalex-snapshot
Molecules targeting the androgen receptor (AR) signaling axis beyond the AR‐Ligand binding domain
inferred← citeshttps://doi.org/10.1002/pros.23719openalex-snapshot
Riluzole induces AR degradation via endoplasmic reticulum stress pathway in androgen‐dependent and castration‐resistant prostate cancer cells
inferred← citeshttps://doi.org/10.1002/slct.202203393openalex-snapshot
Design and Synthesis of New Agents for Prostate Cancer Treatment Inspired by Steroidal CYP17 A1 Inhibitors
inferred← citeshttps://doi.org/10.1002/slct.202401770openalex-snapshot
Pharmacological Perspectives of 2‐alkoxy‐3‐Cyanopyridine Scaffolds: An Up‐to‐Date Review
inferred← citeshttps://doi.org/10.1007/s00044-015-1495-5openalex-snapshot
Development of drugs based on imidazole and benzimidazole bioactive heterocycles: recent advances and future directions
inferred← citeshttps://doi.org/10.1007/s00280-018-3715-4openalex-snapshot
Steroidal dimer by001 inhibits proliferation and migration of esophageal cancer cells via multiple mechanisms
inferred← citeshttps://doi.org/10.1007/s11172-018-2121-8openalex-snapshot
Synthesis of nitrogen-containing derivatives of 17(20)-pregnenoic, 17β-hydroxypregnanoic, and 17α-hydroxypregnanoic acids as new potential antiandrogens
inferred← citeshttps://doi.org/10.1007/s11172-020-2842-3openalex-snapshot
Fluorinated benzimidazoles for medicinal chemistry and new materials
inferred← citeshttps://doi.org/10.1007/s11172-022-3618-8openalex-snapshot
Synthesis of steroids containing N’-alkoxydiazene N-oxide groups
inferred← citeshttps://doi.org/10.1007/s11172-023-3969-9openalex-snapshot
Difluoroborate complexes in the synthesis of heterocyclic (13α)-estrone derivatives modified at the A-ring
inferred← citeshttps://doi.org/10.1007/s12032-016-0759-3openalex-snapshot
Targeting persistent androgen receptor signaling in castration-resistant prostate cancer
inferred← citeshttps://doi.org/10.1016/b978-0-12-409547-2.12396-0openalex-snapshot
Targeting the Androgen Receptor Signaling Axis
inferred← citeshttps://doi.org/10.1016/b978-0-443-23585-6.00007-8openalex-snapshot
Androgen biosynthesis suppressors in prostate cancer therapy
inferred← citeshttps://doi.org/10.1016/bs.aihch.2016.11.002openalex-snapshot
A Synopsis of the Properties and Applications of Heteroaromatic Rings in Medicinal Chemistry
inferred← citeshttps://doi.org/10.1016/bs.vh.2018.01.007openalex-snapshot
Dehydroepiandrosterone (DHEA)-SO 4 Depot and Castration-Resistant Prostate Cancer
inferred← citeshttps://doi.org/10.1016/j.bioorg.2019.103142openalex-snapshot
Novel steroidal 1,3,4-thiadiazines: Synthesis and biological evaluation in androgen receptor-positive prostate cancer 22Rv1 cells
inferred← citeshttps://doi.org/10.1016/j.bioorg.2019.103462openalex-snapshot
Prospective computational design and in vitro bio-analytical tests of new chemical entities as potential selective CYP17A1 lyase inhibitors
inferred← citeshttps://doi.org/10.1016/j.bioorg.2022.106089openalex-snapshot
Targeting androgen receptor for prostate cancer therapy: From small molecules to PROTACs
inferred← citeshttps://doi.org/10.1016/j.bioorg.2023.106700openalex-snapshot
Salinization Dramatically Enhance the Anti-Prostate Cancer Efficacies of AR/AR-V7 and Mnk1/2 Molecular Glue Degraders, Galeterone and VNPP433-3β Which Outperform Docetaxel and Enzalutamide in CRPC CWR22Rv1 Xenograft Mouse Model
inferred← citeshttps://doi.org/10.1016/j.biopha.2024.116934openalex-snapshot
Sterol-like drugs potentiate statin-triggered prostate cancer cell death by inhibiting SREBP2 nuclear translocation
inferred← citeshttps://doi.org/10.1016/j.chembiol.2017.05.020openalex-snapshot
Steroidogenic Metabolism of Galeterone Reveals a Diversity of Biochemical Activities
inferred← citeshttps://doi.org/10.1016/j.csbj.2015.10.001openalex-snapshot
Comparisons of Prostate Cancer Inhibitors Abiraterone and TOK-001 Binding with CYP17A1 through Molecular Dynamics
inferred← citeshttps://doi.org/10.1016/j.ctrv.2015.12.003openalex-snapshot
AR-V7 and prostate cancer: The watershed for treatment selection?
inferred← citeshttps://doi.org/10.1016/j.ejmech.2015.05.010openalex-snapshot
Efficient access to novel androsteno-17-(1′,3′,4′)-oxadiazoles and 17β-(1′,3′,4′)-thiadiazoles via N-substituted hydrazone and N,N′-disubstituted hydrazine intermediates, and their pharmacological evaluation in vitro
inferred← citeshttps://doi.org/10.1016/j.ejmech.2016.05.006openalex-snapshot
Synthesis of novel 17-(4′-formyl)pyrazolylandrosta-5,16-dienes and their derivatives as potent 17α-hydroxylase/C17,20-lyase inhibitors or antiproliferative agents depending on the substitution pattern of the heteroring
inferred← citeshttps://doi.org/10.1016/j.ejmech.2017.03.037openalex-snapshot
Discovery of novel 1,2,3,4-tetrahydrobenzo[4, 5]thieno[2, 3- c ]pyridine derivatives as potent and selective CYP17 inhibitors
inferred← citeshttps://doi.org/10.1016/j.ejmech.2017.10.063openalex-snapshot
Synthesis of unprecedented steroidal spiro heterocycles as potential antiproliferative drugs
inferred← citeshttps://doi.org/10.1016/j.ejmech.2017.12.094openalex-snapshot
Synthesis and biological evaluation of new steroidal pyridines as potential anti-prostate cancer agents
inferred← citeshttps://doi.org/10.1016/j.ejmech.2019.02.025openalex-snapshot
Synthesis and antitumor activity of novel steroidal imidazolium salt derivatives
inferred← citeshttps://doi.org/10.1016/j.ejmech.2019.03.041openalex-snapshot
Discovery and biological evaluation of novel androgen receptor antagonist for castration-resistant prostate cancer
inferred← citeshttps://doi.org/10.1016/j.ejmech.2019.111608openalex-snapshot
Discovery and biological evaluation of darolutamide derivatives as inhibitors and down-regulators of wild-type AR and the mutants
inferred← citeshttps://doi.org/10.1016/j.ejmech.2019.111700openalex-snapshot
1,2,3-Triazole-containing hybrids as potential anticancer agents: Current developments, action mechanisms and structure-activity relationships
inferred← citeshttps://doi.org/10.1016/j.ejmech.2020.112044openalex-snapshot
Artemisinin-derived hybrids and their anticancer activity
inferred← citeshttps://doi.org/10.1016/j.ejmech.2021.113376openalex-snapshot
Identification of novel androgen receptor degrading agents to treat advanced prostate cancer
inferred← citeshttps://doi.org/10.1016/j.ejmech.2021.113420openalex-snapshot
Progress in developing MNK inhibitors
inferred← citeshttps://doi.org/10.1016/j.ejmech.2026.118617openalex-snapshot
Structural optimization of AR and AR-V7 degraders incorporating silicon-based hydrophobic tags for treatment of castration-resistant prostate cancer
inferred← citeshttps://doi.org/10.1016/j.ejmech.2026.119300openalex-snapshot
Synthesis and biological activity of steroid conjugates of five-membered N-heterocycles with one or two nitrogen atoms: A review covering the years 2020-2025
inferred← citeshttps://doi.org/10.1016/j.inoche.2022.109840openalex-snapshot
Synthesis and anticancer evaluation of trinuclear N^N quinolyl-benzimidazole-based PGM complexes
inferred← citeshttps://doi.org/10.1016/j.jorganchem.2020.121285openalex-snapshot
First used of Alkylbenzimidazole-Cobalt(II) complexes as a catalyst for the N-Alkylation of amines with alcohols under solvent-free medium
inferred← citeshttps://doi.org/10.1016/j.jsbmb.2016.04.021openalex-snapshot
The hunt for a selective 17,20 lyase inhibitor; learning lessons from nature
inferred← citeshttps://doi.org/10.1016/j.jsbmb.2016.05.005openalex-snapshot
The fluorescent two-hybrid assay for live-cell profiling of androgen receptor modulators
inferred← citeshttps://doi.org/10.1016/j.jsbmb.2016.06.008openalex-snapshot
C-terminally truncated constitutively active androgen receptor variants and their biologic and clinical significance in castration-resistant prostate cancer
inferred← citeshttps://doi.org/10.1016/j.jsbmb.2016.07.006openalex-snapshot
Dissecting major signaling pathways in prostate cancer development and progression: Mechanisms and novel therapeutic targets
inferred← citeshttps://doi.org/10.1016/j.jsbmb.2018.02.004openalex-snapshot
Discovery and development of ODM-204: A Novel nonsteroidal compound for the treatment of castration-resistant prostate cancer by blocking the androgen receptor and inhibiting CYP17A1
inferred← citeshttps://doi.org/10.1016/j.jsbmb.2019.105499openalex-snapshot
Intracrinology-revisited and prostate cancer
inferred← citeshttps://doi.org/10.1016/j.jsbmb.2019.105506openalex-snapshot
The role of adrenal derived androgens in castration resistant prostate cancer
inferred← citeshttps://doi.org/10.1016/j.jsbmb.2021.105904openalex-snapshot
Synthesis of dihydrotestosterone derivatives modified in the A-ring with (hetero)arylidene, pyrazolo[1,5-a]pyrimidine and triazolo[1,5-a]pyrimidine moieties and their targeting of the androgen receptor in prostate cancer
inferred← citeshttps://doi.org/10.1016/j.jsbmb.2021.105997openalex-snapshot
Heterocyclic androstane and estrane d-ring modified steroids: Microwave-assisted synthesis, steroid-converting enzyme inhibition, apoptosis induction, and effects on genes encoding estrogen inactivating enzymes
inferred← citeshttps://doi.org/10.1016/j.jsbmb.2022.106245openalex-snapshot
Secosteroid–quinoline hybrids as new anticancer agents
inferred← citeshttps://doi.org/10.1016/j.jsbmb.2023.106280openalex-snapshot
Oxazolinyl derivatives of androst-16-ene as inhibitors of CYP17A1 activity and prostate carcinoma cells proliferation: Effects of substituents in oxazolinyl moiety
inferred← citeshttps://doi.org/10.1016/j.jsbmb.2023.106309openalex-snapshot
Discovery of highly potent proapoptotic antiestrogens in a series of androst-5,16-dienes D-modified with imidazole-annulated pendants
inferred← citeshttps://doi.org/10.1016/j.jsbmb.2023.106315openalex-snapshot
Dihydrotestosterone-based A-ring-fused pyridines: Microwave-assisted synthesis and biological evaluation in prostate cancer cells compared to structurally related quinolines
inferred← citeshttps://doi.org/10.1016/j.jsbmb.2023.106386openalex-snapshot
Secosteroid thiosemicarbazides and secosteroid–1,2,4-triazoles as antiproliferative agents targeting breast cancer cells: Synthesis and biological evaluation
inferred← citeshttps://doi.org/10.1016/j.mce.2017.08.020openalex-snapshot
Treatment-induced changes in the androgen receptor axis: Liquid biopsies as diagnostic/prognostic tools for prostate cancer
inferred← citeshttps://doi.org/10.1016/j.molstruc.2016.06.017openalex-snapshot
Syntheses and molecular structures of novel Ru(II) complexes with bidentate benzimidazole based ligands and their catalytic efficiency for oxidation of benzyl alcohol
inferred← citeshttps://doi.org/10.1016/j.molstruc.2022.132577openalex-snapshot
Synthesis, structural, computational, and antiproliferative activity studies of new steroidal tetrazole derivatives
inferred← citeshttps://doi.org/10.1016/j.molstruc.2022.133692openalex-snapshot
Synthesis of new morpholine-benzimidazole-pyrazole hybrids as tubulin polymerization inhibiting anticancer agents
inferred← citeshttps://doi.org/10.1016/j.molstruc.2024.140324openalex-snapshot
Exploring the molecular insights of imidazole and benzimidazole scaffold for cancer therapy: Synthesis, in-vitro cytotoxicity and SAR studies
inferred← citeshttps://doi.org/10.1016/j.phrs.2016.10.001openalex-snapshot
Androgen receptor variation affects prostate cancer progression and drug resistance
inferred← citeshttps://doi.org/10.1016/j.procbio.2016.08.016openalex-snapshot
Oxidant and antioxidant status in Saccharomyces cerevisiae exposed to antifungal ketoconazole
inferred← citeshttps://doi.org/10.1016/j.steroids.2015.07.005openalex-snapshot
Efficient three-component one-pot synthesis of steroidal polysubstituted anilines
inferred← citeshttps://doi.org/10.1016/j.steroids.2015.08.003openalex-snapshot
Efficient synthesis of novel antiproliferative steroidal spirooxindoles via the [3+2] cycloaddition reactions of azomethine ylides
inferred← citeshttps://doi.org/10.1016/j.steroids.2016.03.005openalex-snapshot
Multicomponent assembly of novel antiproliferative steroidal dihydropyridinyl spirooxindoles
inferred← citeshttps://doi.org/10.1016/j.steroids.2016.06.002openalex-snapshot
Oxazolinyl derivatives of [17(20)E]-21-norpregnene differing in the structure of A and B rings. Facile synthesis and inhibition of CYP17A1 catalytic activity
inferred← citeshttps://doi.org/10.1016/j.steroids.2016.09.005openalex-snapshot
Solvent-free synthesis of novel steroidal 2-aminopyridines
inferred← citeshttps://doi.org/10.1016/j.steroids.2017.03.006openalex-snapshot
Synthesis and anti-cancer activity of chiral tetrahydropyrazolo[1,5- a ]pyridine-fused steroids
inferred← citeshttps://doi.org/10.1016/j.steroids.2017.11.009openalex-snapshot
Comparison of [17(20)E]-21-Norpregnene oxazolinyl and benzoxazolyl derivatives as inhibitors of CYP17A1 activity and prostate carcinoma cells growth
inferred← citeshttps://doi.org/10.1016/j.steroids.2018.03.006openalex-snapshot
Synthesis of novel 17-triazolyl-androst-5-en-3-ol epimers via Cu(I)-catalyzed azide-alkyne cycloaddition and their inhibitory effect on 17α-hydroxylase/C 17,20 -lyase
inferred← citeshttps://doi.org/10.1016/j.steroids.2018.06.011openalex-snapshot
Conjugates of 17-substituted testosterone and epitestosterone with pyropheophorbide a differing in the length of linkers
inferred← citeshttps://doi.org/10.1016/j.steroids.2019.03.003openalex-snapshot
Design and synthesis of novel steroidal imidazoles as dual inhibitors of AR/CYP17 for the treatment of prostate cancer
inferred← citeshttps://doi.org/10.1016/j.steroids.2019.03.012openalex-snapshot
Synthesis and evaluation of novel D-ring substituted steroidal pyrazolines as potential anti-inflammatory agents
inferred← citeshttps://doi.org/10.1016/j.steroids.2019.108465openalex-snapshot
Synthesis of new steroidal quinolines with antitumor properties
inferred← citeshttps://doi.org/10.1016/j.steroids.2019.108534openalex-snapshot
New steroidal oxazolines, benzoxazoles and benzimidazoles related to abiraterone and galeterone
inferred← citeshttps://doi.org/10.1016/j.steroids.2022.109062openalex-snapshot
Large-scale synthesis of galeterone and lead next generation galeterone analog VNPP433-3β
inferred← citeshttps://doi.org/10.1016/j.steroids.2023.109184openalex-snapshot
Murine toxicology and pharmacokinetics of lead next generation galeterone analog, VNPP433-3β
inferred← citeshttps://doi.org/10.1016/j.steroids.2024.109475openalex-snapshot
Steroidal 21-imidazolium salt derivatives: Synthesis and anticancer activity
inferred← citeshttps://doi.org/10.1016/j.tet.2022.132991openalex-snapshot
New molecular hybrids containing benzimidazole, thiazolidine-2,4-dione and 1,2,4-oxadiazole as EGFR directing cytotoxic agents
inferred← citeshttps://doi.org/10.1016/j.tiv.2022.105332openalex-snapshot
Exploration of structural requirements for azole chemicals towards human aromatase CYP19A1 activity: Classification modeling, structure-activity relationships and read-across study
inferred← citeshttps://doi.org/10.1016/j.urolonc.2016.05.002openalex-snapshot
Utility of novel androgen receptor therapies in the real world: A nuanced approach
inferred← citeshttps://doi.org/10.1021/acs.chemrev.8b00031openalex-snapshot
Formation and Cleavage of C–C Bonds by Enzymatic Oxidation–Reduction Reactions
inferred← citeshttps://doi.org/10.1021/acs.jafc.1c06075openalex-snapshot
Synthesis, Crystal Structure, and Insecticidal Activity of Steroidal N-Piperidone
inferred← citeshttps://doi.org/10.1021/acs.jcim.7b00137openalex-snapshot
Best Practices of Computer-Aided Drug Discovery: Lessons Learned from the Development of a Preclinical Candidate for Prostate Cancer with a New Mechanism of Action
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.2c01164openalex-snapshot
Design, Synthesis, and Biological Evaluation of Androgen Receptor Degrading and Antagonizing Bifunctional Steroidal Analogs for the Treatment of Advanced Prostate Cancer
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.2c01487openalex-snapshot
A Comprehensive Overview of Small-Molecule Androgen Receptor Degraders: Recent Progress and Future Perspectives
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.3c00880openalex-snapshot
Discovery of a Novel Bifunctional Steroid Analog, YXG-158, as an Androgen Receptor Degrader and CYP17A1 Inhibitor for the Treatment of Enzalutamide-Resistant Prostate Cancer
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.3c02177openalex-snapshot
Structure–Activity Relationship (SAR) Studies of Novel Monovalent AR/AR-V7 Dual Degraders with Potent Efficacy against Advanced Prostate Cancer
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.4c03043openalex-snapshot
Discovery of Novel Bifunctional Agents as Potent Androgen Receptor Antagonists and Degraders for the Treatment of Enzalutamide-Resistant Prostate Cancer
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.8b00419openalex-snapshot
Structure-Based Design of Inhibitors with Improved Selectivity for Steroidogenic Cytochrome P450 17A1 over Cytochrome P450 21A2
inferred← citeshttps://doi.org/10.1021/acs.joc.4c00803openalex-snapshot
Synthesis of N-Alkenylated Heterocycles via T3P-Promoted Condensation with Ketones
inferred← citeshttps://doi.org/10.1021/acs.oprd.6b00217openalex-snapshot
Improved Procedures for Gram-Scale Synthesis of Galeterone 3β-Imidazole and Galeterone 3β-Pyridine Methoxylate, Potent Androgen Receptor/Mnk Degrading Agents
inferred← citeshttps://doi.org/10.1021/acs.orglett.8b01783openalex-snapshot
Reactivity of Steroidal 1-Azadienes toward Carbonyl Compounds under Enamine Catalysis: Chiral Penta- and Hexacyclic Steroids
inferred← citeshttps://doi.org/10.1021/acsmedchemlett.6b00137openalex-snapshot
Identification of Novel Steroidal Androgen Receptor Degrading Agents Inspired by Galeterone 3β-Imidazole Carbamate
inferred← citeshttps://doi.org/10.1021/acsmedchemlett.6b00186openalex-snapshot
Small Molecule Antagonists of the Nuclear Androgen Receptor for the Treatment of Castration-Resistant Prostate Cancer
inferred← citeshttps://doi.org/10.1021/acsomega.0c00630openalex-snapshot
Molecular Hybrids Integrated with Benzimidazole and Pyrazole Structural Motifs: Design, Synthesis, Biological Evaluation, and Molecular Docking Studies
inferred← citeshttps://doi.org/10.1021/acsomega.2c06057openalex-snapshot
Novel 1,2,5-Trisubstituted Benzimidazoles Potentiate Apoptosis by Mitochondrial Dysfunction in Panel of Cancer Cells
inferred← citeshttps://doi.org/10.1021/acsomega.3c00098openalex-snapshot
Synthesis of Carlactone Derivatives to Develop a Novel Inhibitor of Strigolactone Biosynthesis
inferred← citeshttps://doi.org/10.1021/acssuschemeng.7b01495openalex-snapshot
Benzimidazolines Convert Sulfur Dioxide to Bisulfate at Room Temperature and Atmospheric Pressure Utilizing Aerial Oxygen
inferred← citeshttps://doi.org/10.1021/jm501792copenalex-snapshot
Novel C-4 Heteroaryl 13-cis-Retinamide Mnk/AR Degrading Agents Inhibit Cell Proliferation and Migration and Induce Apoptosis in Human Breast and Prostate Cancer Cells and Suppress Growth of MDA-MB-231 Human Breast and CWR22Rv1 Human Prostate Tumor Xenografts in Mice
inferred← citeshttps://doi.org/10.1038/nrurol.2018.22openalex-snapshot
Cellular plasticity and the neuroendocrine phenotype in prostate cancer
inferred← citeshttps://doi.org/10.1038/pcan.2016.31openalex-snapshot
Predictors of duration of abiraterone acetate in men with castration-resistant prostate cancer
inferred← citeshttps://doi.org/10.1038/s41392-022-01042-7openalex-snapshot
Targeting signaling pathways in prostate cancer: mechanisms and clinical trials
inferred← citeshttps://doi.org/10.1038/s41585-020-0298-8openalex-snapshot
Cellular rewiring in lethal prostate cancer: the architect of drug resistance
inferred← citeshttps://doi.org/10.1038/srep31607openalex-snapshot
Structurally novel steroidal spirooxindole by241 potently inhibits tumor growth mainly through ROS-mediated mechanisms
inferred← citeshttps://doi.org/10.1039/c6cc08680bopenalex-snapshot
Structure-based optimisation of non-steroidal cytochrome P450 17A1 inhibitors
inferred← citeshttps://doi.org/10.1039/d5md00954eopenalex-snapshot
Strategies to inhibit steroid cytochrome P450 enzymes to benefit human health: development of steroid ligands for P450s 17A1, 19A1, and 8B1 to treat cancer and obesity
inferred← citeshttps://doi.org/10.1039/d6ob00051gopenalex-snapshot
Positional isomerization of N -allyl compounds with a practical low-valent cobalt catalyst system
inferred← citeshttps://doi.org/10.1055/a-2520-0317openalex-snapshot
A General Route to 3-Thiosubstituted Steroids via Copper-Catalyzed C–S Coupling
inferred← citeshttps://doi.org/10.1074/jbc.m117.794917openalex-snapshot
Kinetic processivity of the two-step oxidations of progesterone and pregnenolone to androgens by human cytochrome P450 17A1
inferred← citeshttps://doi.org/10.1074/jbc.ra117.000504openalex-snapshot
Inherent steroid 17α,20-lyase activity in defunct cytochrome P450 17A enzymes
inferred← citeshttps://doi.org/10.1080/14656566.2018.1548611openalex-snapshot
Perspectives on the current and emerging chemical androgen receptor antagonists for the treatment of prostate cancer
inferred← citeshttps://doi.org/10.1080/14728222.2016.1214400openalex-snapshot
Response: letter to the editor
inferred← citeshttps://doi.org/10.1080/14756366.2021.1958212openalex-snapshot
New benzothieno[2,3-c]pyridines as non-steroidal CYP17 inhibitors: design, synthesis, anticancer screening, apoptosis induction, and in silico ADME profile studies
inferred← citeshttps://doi.org/10.1080/14756366.2025.2483818openalex-snapshot
Discovery and development of steroidal enzyme inhibitors as anti-cancer drugs: state-of-the-art and future perspectives
inferred← citeshttps://doi.org/10.1093/med/9780198870197.003.0221openalex-snapshot
Hormonal Therapy for Prostate Cancer
inferred← citeshttps://doi.org/10.1096/fj.202403170rropenalex-snapshot
Cell‐ ELISA ‐Based High‐Throughput Screening Leads to the Discovery of Androgen Receptor Degraders to Conquer Castration‐Resistant Prostate Cancer
inferred← citeshttps://doi.org/10.1097/med.0000000000000254openalex-snapshot
Novel mechanism-based therapeutics for androgen axis blockade in castration-resistant prostate cancer
inferred← citeshttps://doi.org/10.1101/2023.10.31.564977openalex-snapshot
Essential oil terpenes may inhibit steroidogenic cytochrome P450 activities
inferred← citeshttps://doi.org/10.1111/febs.13895openalex-snapshot
Galeterone and VNPT 55 disrupt Mnk‐ eIF 4E to inhibit prostate cancer cell migration and invasion
inferred← citeshttps://doi.org/10.1111/iju.12907openalex-snapshot
Novel agents for castration‐resistant prostate cancer: Early experience and beyond
inferred← citeshttps://doi.org/10.1111/iju.13137openalex-snapshot
Androgen receptor targeted therapies in castration‐resistant prostate cancer: Bench to clinic
inferred← citeshttps://doi.org/10.1134/s1068162024040307openalex-snapshot
Design and Synthesis of Some New Benzimidazole-1,2,3-triazole-thiazolidine-2,4-dione Conjugates as Tubulin Polymerization Inhibitors
inferred← citeshttps://doi.org/10.1134/s106816202405025xopenalex-snapshot
In Vitro Antibreast Cancer and Anti-EGFR Studies of Some Novel Benzimidazole-Piperazine Containing 1,2,3-Triazoles
inferred← citeshttps://doi.org/10.1134/s1990750819040073openalex-snapshot
Synthesis and Evaluation of N-Alkynylaminosteroids as Potential Inhibitors of CYP450 17A1
inferred← citeshttps://doi.org/10.1146/annurev-pharmtox-030624-110238openalex-snapshot
PROTACs as Therapeutic Modalities for Drug Discovery in Castration-Resistant Prostate Cancer
inferred← citeshttps://doi.org/10.1177/1758834016642370openalex-snapshot
CYP17 inhibitors in prostate cancer: latest evidence and clinical potential
inferred← citeshttps://doi.org/10.1186/s13045-015-0225-2openalex-snapshot
Persistent androgen receptor addiction in castration-resistant prostate cancer
inferred← citeshttps://doi.org/10.1208/s12249-023-02597-6openalex-snapshot
Can the Oral Bioavailability of the Discontinued Prostate Cancer Drug Galeterone Be Improved by Processing Method? KinetiSol® Outperforms Spray Drying in a Head-to-head Comparison
inferred← citeshttps://doi.org/10.1248/cpb.c17-00922openalex-snapshot
Synthesis of Novel Thiophene, Thiazole and Coumarin Derivatives Based on Benzimidazole Nucleus and Their Cytotoxicity and Toxicity Evaluations
inferred← citeshttps://doi.org/10.14288/1.0165754openalex-snapshot
Discovery of novel androgen receptor inhibitors as prospective therapeutics for advanced prostate cancer
inferred← citeshttps://doi.org/10.1517/13543784.2016.1162784openalex-snapshot
Phase I and II therapies targeting the androgen receptor for the treatment of castration resistant prostate cancer
inferred← citeshttps://doi.org/10.1530/ec-17-0118openalex-snapshot
Clinical relevance of androgen receptor alterations in prostate cancer
inferred← citeshttps://doi.org/10.1530/erc-16-0298openalex-snapshot
Emerging data on androgen receptor splice variants in prostate cancer
inferred← citeshttps://doi.org/10.1530/erc-16-0422openalex-snapshot
Androgen receptor signaling in castration-resistant prostate cancer: a lesson in persistence
inferred← citeshttps://doi.org/10.1530/erc-17-0108openalex-snapshot
Allosteric alterations in the androgen receptor and activity in prostate cancer
inferred← citeshttps://doi.org/10.1530/erc-17-0136openalex-snapshot
Molecular underpinnings of enzalutamide resistance
inferred← citeshttps://doi.org/10.1530/erc-17-0145openalex-snapshot
Androgen deprivation and immunotherapy for the treatment of prostate cancer
inferred← citeshttps://doi.org/10.1556/650.2017.30597openalex-snapshot
Androgénreceptor mediálta folyamatok metasztatikus kasztrációrezisztens prosztatadaganatban
inferred← citeshttps://doi.org/10.1615/critrevoncog.2024056541openalex-snapshot
Investigation of Benzimidazole Derivatives in Molecular Targets for Breast Cancer Treatment: A Comprehensive Review
inferred← citeshttps://doi.org/10.1634/theoncologist.2016-0161openalex-snapshot
Targeting the N-Terminal Domain of the Androgen Receptor: A New Approach for the Treatment of Advanced Prostate Cancer
inferred← citeshttps://doi.org/10.17816/onco692371openalex-snapshot
Search for New antineoplastic agents based on structural modifications of steroidal 5α-reductase, 17β-hydroxysteroid dehydrogenase, and 17α-hydroxylase/17,20-lyase inhibitors
inferred← citeshttps://doi.org/10.18097/bmcrm00008openalex-snapshot
Investigation in silico the interaction of oxazolinyl derivatives of [17(20)E]-21-norpregnene with androgen receptor
inferred← citeshttps://doi.org/10.18097/bmcrm00020openalex-snapshot
Steroidal Inhibitors of CYP17A1 as a Template For Novel Anti-Cancer Agents Development
inferred← citeshttps://doi.org/10.18097/bmcrm00241openalex-snapshot
New Nitrogen-containing Androstane Derivatives Suppressing Prostate Carcinoma Cells Proliferation
inferred← citeshttps://doi.org/10.18097/pbmc20196504324openalex-snapshot
Synthesis and evaluation of N-alkynylaminosteroids as potential CYP450 17A1 inhibitors
inferred← citeshttps://doi.org/10.18632/oncotarget.14154openalex-snapshot
Galeterone and its analogs inhibit Mnk-eIF4E axis, synergize with gemcitabine, impede pancreatic cancer cell migration, invasion and proliferation and inhibit tumor growth in mice
inferred← citeshttps://doi.org/10.18632/oncotarget.14537openalex-snapshot
Androgen receptor splice variants and prostate cancer: From bench to bedside
inferred← citeshttps://doi.org/10.18632/oncotarget.25167openalex-snapshot
The novel anti-androgen candidate galeterone targets deubiquitinating enzymes, USP12 and USP46, to control prostate cancer growth and survival
inferred← citeshttps://doi.org/10.18632/oncotarget.4578openalex-snapshot
Galeterone and VNPT55 induce proteasomal degradation of AR/AR-V7, induce significant apoptosis via cytochrome c release and suppress growth of castration resistant prostate cancer xenograftsin vivo
inferred← citeshttps://doi.org/10.20517/2394-4722.2017.44openalex-snapshot
Androgen-AR axis in primary and metastatic prostate cancer: chasing steroidogenic enzymes for therapeutic intervention
inferred← citeshttps://doi.org/10.20517/cdr.2020.60openalex-snapshot
Intracrine androgen biosynthesis and drug resistance
inferred← citeshttps://doi.org/10.20892/j.issn.2095-3941.2022.0714openalex-snapshot
Therapeutic implications of cancer stem cells in prostate cancer
inferred← citeshttps://doi.org/10.21037/tcr.2017.08.29openalex-snapshot
Androgen receptor antagonism and impact on inhibitors of androgen synthesis in prostate cancer therapy
inferred← citeshttps://doi.org/10.21203/rs.3.rs-9762220/v1openalex-snapshot
Targeting V-ATPase-Mediated Lysosomal Acidification: Antitumor Mechanisms of Steroidal Compounds
inferred← citeshttps://doi.org/10.2147/dddt.s93941openalex-snapshot
Galeterone for the treatment of advanced prostate cancer: the evidence to date
inferred← citeshttps://doi.org/10.2147/ott.s242921openalex-snapshot
A Clinical Evaluation of Enzalutamide in Metastatic Castration-Sensitive Prostate Cancer: Guiding Principles for Treatment Selection and Perspectives on Research
inferred← citeshttps://doi.org/10.2174/0115680266283641240109080047openalex-snapshot
Unlocking the Pharmacological Potential of Benzimidazole Derivatives: A Pathway to Drug Development
inferred← citeshttps://doi.org/10.2174/0115734064320533240903062533openalex-snapshot
Pharmacological Evaluation of Bioisosterically Replaced and Triazole- Tethered Derivatives for Anticancer Therapy
inferred← citeshttps://doi.org/10.2174/0929867325666180913095239openalex-snapshot
Non-Steroidal Androgen Receptor Antagonists and Prostate Cancer: A Survey on Chemical Structures Binding this Fast-Mutating Target
inferred← citeshttps://doi.org/10.2174/1389200223666220401093833openalex-snapshot
Insights into Interactions of Human Cytochrome P450 17A1: A Review
inferred← citeshttps://doi.org/10.2174/1389557521666211001122118openalex-snapshot
Synthetic Approach to Potential Anticancer Benzimidazole Derivatives: A Review
inferred← citeshttps://doi.org/10.2174/1568026620666200128143230openalex-snapshot
Recent Development of 1,2,4-triazole-containing Compounds as Anticancer Agents
inferred← citeshttps://doi.org/10.2174/1871520620666200721111230openalex-snapshot
New Approaches for the Synthesis of Heterocyclic Compounds Corporating Benzo[d]imidazole as Anticancer Agents, Tyrosine, Pim-1 Kinases Inhibitions and their PAINS Evaluations
inferred← citeshttps://doi.org/10.3389/fchem.2026.1988344openalex-snapshot
Cytochrome P450 inhibitors: friends or foes?
inferred← citeshttps://doi.org/10.3389/fonc.2016.00024openalex-snapshot
Mechanistic Insights into Molecular Targeting and Combined Modality Therapy for Aggressive, Localized Prostate Cancer
inferred← citeshttps://doi.org/10.3389/fonc.2019.00801openalex-snapshot
Second-Generation Antiandrogens: From Discovery to Standard of Care in Castration Resistant Prostate Cancer
inferred← citeshttps://doi.org/10.3390/biom14020203openalex-snapshot
Effect of Essential Oil Components on the Activity of Steroidogenic Cytochrome P450
inferred← citeshttps://doi.org/10.3390/cancers11111637openalex-snapshot
Galeterone and The Next Generation Galeterone Analogs, VNPP414 and VNPP433-3β Exert Potent Therapeutic Effects in Castration-/Drug-Resistant Prostate Cancer Preclinical Models In Vitro and In Vivo
inferred← citeshttps://doi.org/10.3390/cells11172699openalex-snapshot
Novel AR/AR-V7 and Mnk1/2 Degrader, VNPP433-3β: Molecular Mechanisms of Action and Efficacy in AR-Overexpressing Castration Resistant Prostate Cancer In Vitro and In Vivo Models
inferred← citeshttps://doi.org/10.3390/cryst10090786openalex-snapshot
Synthesis and Structure of Fluorinated (Benzo[d]imidazol-2-yl)methanols: Bench Compounds for Diverse Applications
inferred← citeshttps://doi.org/10.3390/ijms161126036openalex-snapshot
Prostate Cancer Stem Cells: Research Advances
inferred← citeshttps://doi.org/10.3390/ijms22042124openalex-snapshot
An Overview of Next-Generation Androgen Receptor-Targeted Therapeutics in Development for the Treatment of Prostate Cancer
inferred← citeshttps://doi.org/10.3390/ijms232113534openalex-snapshot
Synthesis and Biological Evaluation of New Isoxazolyl Steroids as Anti-Prostate Cancer Agents
inferred← citeshttps://doi.org/10.3390/pharmaceutics16111401openalex-snapshot
Abiraterone and Galeterone, Powerful Tools Against Prostate Cancer: Present and Perspective
inferred← citeshttps://doi.org/10.37021/ijper.v5i2.02openalex-snapshot
The Molecular Docking Studies of Benzimidazole Analogues as Novel Anti-Inflammatory Agents
inferred← citeshttps://doi.org/10.3762/bjoc.14.236openalex-snapshot
Microwave-assisted synthesis of biologically relevant steroidal 17-exo-pyrazol-5'-ones from a norpregnene precursor by a side-chain elongation/heterocyclization sequence
inferred← citeshttps://doi.org/10.4081/oncol.2016.297openalex-snapshot
Splice variants of androgen receptor and prostate cancer
inferred← citeshttps://doi.org/10.4103/jcrt.jcrt_295_18openalex-snapshot
CYP17 inhibitors improve the prognosis of metastatic castration-resistant prostate cancer patients: A meta-analysis of published trials
inferred← citeshttps://doi.org/10.4155/fmc.16.12openalex-snapshot
Progress in the Mechanism and Drug Development of Castration-Resistant Prostate Cancer
inferred← citeshttps://doi.org/10.5772/intechopen.101702openalex-snapshot
Advances of Benzimidazole Derivatives as Anticancer Agents: Bench to Bedside
inferred← citeshttps://doi.org/10.5772/intechopen.102091openalex-snapshot
Benzimidazole: Pharmacological Profile
inferred← citeshttps://doi.org/10.5772/intechopen.86691openalex-snapshot
Development of Benzimidazole Compounds for Cancer Therapy
inferred← citeshttps://doi.org/10.5772/intechopen.87174openalex-snapshot
Introductory Chapter: Short Insight in Synthesis and Applications of Benzimidazole and Its Derivatives
inferred← citeshttps://doi.org/10.58806/ijhmr.2025.v4i1n01openalex-snapshot
Classification and Mechanism of Action of Anti-Parasitic Drugs: A Review Article
inferred← citeshttps://doi.org/10.59429/ace.v7i2.1864openalex-snapshot
Molecular docking, pharmacokinetic profiling and toxicity studies of 2-substituted benzimidazole derivatives against breast cancer
inferred← citeshttps://doi.org/10.7150/ijbs.14090openalex-snapshot
Therapeutic Rationales, Progresses, Failures, and Future Directions for Advanced Prostate Cancer
inferred← citeshttps://doi.org/10.7888/juoeh.38.129openalex-snapshot
Role of the Androgen-Androgen Receptor Axis in the Treatment Resistance of Advanced Prostate Cancer: From Androgen-Dependent to Castration Resistant and Further
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.